197 related articles for article (PubMed ID: 23517562)
1. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
[TBL] [Abstract][Full Text] [Related]
2. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.
Carella AM; de Souza CA; Luminari S; Marcheselli L; Chiappella A; di Rocco A; Cesaretti M; Rossi A; Rigacci L; Gaidano G; Merli F; Spina M; Stelitano C; Hohaus S; Barbui A; Puccini B; Miranda EC; Guida A; Federico M
Leuk Lymphoma; 2013 Jan; 54(1):53-7. PubMed ID: 22712840
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
[TBL] [Abstract][Full Text] [Related]
6. Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Tucci A; Arcari A; Rigacci L; Hawkes E; Chiattone CS; Cavallo F; Cabras G; Alvarez I; Fabbri A; Re A; Puccini B; Barraclough A; Delamain MT; Ferrero S; Usai SV; Ferrari A; Cencini E; Pennese E; Zilioli VR; Marino D; Balzarotti M; Cox MC; Zanni M; Di Rocco A; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Nassi L; Musuraca G; Tani M; Bottelli C; Kovalchuk S; Re F; Flenghi L; Molinari A; Tarantini G; Chimienti E; Marcheselli L; Mammi C; Spina M
J Clin Oncol; 2021 Apr; 39(11):1214-1222. PubMed ID: 33577377
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Gini G; Tani M; Tucci A; Marcheselli L; Cesaretti M; Bellei M; Pascarella A; Ballerini F; Petrini M; Merli F; Olivieri A; Lanza F; Annibali O; Zilioli VR; Liberati AM; Tisi MC; Arcari A; Marino D; Musuraca G; Pavone V; Fabbri A; Pozzi S; Mannina D; Plenteda C; Celli M; Luminari S
Blood; 2023 Oct; 142(17):1438-1447. PubMed ID: 37418685
[TBL] [Abstract][Full Text] [Related]
8. [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China].
Zhang CL; Feng R; Li JT; Tian Y; Wang T; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):271-276. PubMed ID: 29779319
[No Abstract] [Full Text] [Related]
9. Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment.
Yoshida M; Nakao T; Horiuchi M; Ueda H; Hagihara K; Kanashima H; Inoue T; Sakamoto E; Hirai M; Koh H; Nakane T; Hino M; Yamane T
Eur J Haematol; 2016 Apr; 96(4):409-16. PubMed ID: 26084899
[TBL] [Abstract][Full Text] [Related]
10. R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
Laribi K; Denizon N; Bolle D; Truong C; Besançon A; Sandrini J; Anghel A; Farhi J; Ghnaya H; Baugier de Materre A
Ann Hematol; 2016 Oct; 95(10):1705-14. PubMed ID: 27485454
[TBL] [Abstract][Full Text] [Related]
11. Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Tucci A; Merli F; Fabbri A; Marcheselli L; Pagani C; Puccini B; Marino D; Zanni M; Pennese E; Flenghi L; Arcari A; Botto B; Celli M; Mammi C; Re A; Campostrini G; Tafuri A; Zilioli VR; Cencini E; Sartori R; Bottelli C; Merli M; Petrucci L; Gini G; Balzarotti M; Cavallo F; Musuraca G; Luminari S; Rossi G; Spina M
Haematologica; 2023 Apr; 108(4):1083-1091. PubMed ID: 36384247
[TBL] [Abstract][Full Text] [Related]
12. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.
Merli M; Visco C; Spina M; Luminari S; Ferretti VV; Gotti M; Rattotti S; Fiaccadori V; Rusconi C; Targhetta C; Stelitano C; Levis A; Ambrosetti A; Rossi D; Rigacci L; D'Arco AM; Musto P; Chiappella A; Baldini L; Bonfichi M; Arcaini L
Haematologica; 2014 Mar; 99(3):489-96. PubMed ID: 24270404
[TBL] [Abstract][Full Text] [Related]
13. Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).
Zallio F; Tamiazzo S; Monagheddu C; Merli F; Ilariucci F; Stelitano C; Liberati AM; Mannina D; Vitolo U; Angelucci E; Rota Scalabrini D; Vallisa D; Bellei M; Bari A; Ciccone G; Salvi F; Levis A
Br J Haematol; 2016 Mar; 172(6):879-88. PubMed ID: 26763986
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Park S; Hong J; Hwang I; Ahn JY; Cho EY; Park J; Cho EK; Shin DB; Lee JH
J Geriatr Oncol; 2015 Nov; 6(6):470-8. PubMed ID: 26522808
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.
Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Tucci A; Ilariucci F; Chiappella A; Musso M; Di Rocco A; Stelitano C; Alvarez I; Baldini L; Mazza P; Salvi F; Arcari A; Fragasso A; Gobbi PG; Liberati AM; Federico M
Leuk Lymphoma; 2012 Apr; 53(4):581-8. PubMed ID: 21895543
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Vitolo U; Chiappella A; Franceschetti S; Carella AM; Baldi I; Inghirami G; Spina M; Pavone V; Ladetto M; Liberati AM; Molinari AL; Zinzani P; Salvi F; Fattori PP; Zaccaria A; Dreyling M; Botto B; Castellino A; Congiu A; Gaudiano M; Zanni M; Ciccone G; Gaidano G; Rossi G;
Lancet Oncol; 2014 Jun; 15(7):730-7. PubMed ID: 24831981
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
Allen P
Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma.
Tanaka T; Sakai R; Choi I; Tsukada J; Sasaki H; Naito Y; Kiyomi F; Takamatsu Y; Tamura K
Sci Rep; 2022 Feb; 12(1):3124. PubMed ID: 35210509
[TBL] [Abstract][Full Text] [Related]
20. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
